首页> 外文期刊>Leukemia and lymphoma >Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy
【24h】

Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy

机译:原发放疗治疗眼眶淋巴瘤的长期结果和失败模式

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this study was to evaluate the long-term outcome and patterns of failure in patients treated with primary radiotherapy (RT) for orbital lymphoma (OL). Seventy-nine patients diagnosed with stage IE OL between 1995 and 2012 were included. Fifty-nine patients (75%) had mucosa-associated lymphoid tissue lymphoma and 20 patients (25%) had follicular lymphoma subtype. The median follow-up was 49.7 months. Major tumor sites were conjunctiva (29%), orbit (47%) and lacrimal gland (24%). After treatment to a median dose of 30.6 Gy, there were a total of no local, one contralateral orbital, two regional and two distant recurrences, all outside of the treatment fields. The 10-year local relapse-free, distant metastasis-free and overall survival rates were 100%, 94.2% and 98.2%, respectively. Definitive RT to 30 Gy was shown to be highly effective for indolent OL, and this study represents one of the largest single-institution studies using primary RT for stage IE OL.
机译:这项研究的目的是评估接受眼眶淋巴瘤原发放疗(RT)的患者的长期结果和失败模式。纳入1995年至2012年间诊断为IE OL期的79位患者。 59名患者(75%)患有粘膜相关淋巴样组织淋巴瘤,20名患者(25%)患有滤泡性淋巴瘤亚型。中位随访时间为49.7个月。主要的肿瘤部位是结膜(29%),眼眶(47%)和泪腺(24%)。在中位剂量为30.6 Gy的治疗后,在治疗区域之外,总共没有局部,一对对侧眼眶,两个区域性和两个远处复发。 10年无局部复发,无远处转移和总生存率分别为100%,94.2%和98.2%。最终的RT至30 Gy被证明对惰性OL非常有效,并且该研究代表了最大的单机构研究之一,该研究采用了用于IE OL期的主要RT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号